Home LiteratureArticle Details
PMID: 4126764 Published · ppublish English Journal Article

A sequence of biochemical events in the antigen-induced release of chemical mediators from sensitized human lung tissue.

The Journal of experimental medicine ·Vol. 138 ·No. 5 ·1973-11-01 ·Pages 1077-94

Kaliner M, Austen KF

Abstract

Five sequential steps interspaced between the antigen activation of human lung fragments sensitized with IgE and the release of the chemical mediators, histamine and slow-reacting substance of anaphylaxis (SRS-A), have been delineated. The experimental design that permits this analysis is based upon the capacity to maintain the serine esterase essential to mediator release in its diisopropylphosphofluoridate (DFP)-resistant precursor state despite antigen challenge and upon the ability to arrest reversibly the reaction sequence by various manipulations. When sensitized lung fragments are challenged with antigen in the presence of DFP, a serine esterase is converted to its active DFP-inhibitable state; this conversion is prevented if antigen challenge in the presence of DFP occurs in calcium-free buffer indicating that immunologic activation of the esterase requires extracellular calcium. The fact that calcium depletion alone does not impair antigen-induced histamine release implies that prevention of esterase activation depends upon both the absence of extracellular calcium and the inactivation of any active esterase by DFP to prevent an autocatalytic feedback activation. Arresting the antigen-induced activation of the serine esterase by the combination of DFP in calcium-free buffer precludes the sequence from reaching the labile, 2-deoxyglucose (2-DG)-inhibitable, energy-requiring step, indicating that proesterase activation precedes this energy-requiring stage. The 2-DG-inhibitable step precedes a second calcium-requiring, EDTA-inhibitable stage, as EDTA prevents glucose reversal of 2-DG inhibition of antigen-challenged tissue, while the presence of 2-DG does not prevent calcium reversal of EDTA inhibition. The finding that isoproterenol prevents calcium reversal of EDTA inhibition of mediator release suggests that the inhibitory site of action of increased concentrations of cyclic AMP is coincident with or subsequent to the second calcium-requiring, EDTA-inhibitable step. Therefore, the sequence of biochemical events initiated by the interaction of antigen with tissue-fixed IgE antibodies appears to proceed from the calcium-requiring activation of a DFP-sensitive serine esterase; the further autocatalytic activation of the esterase; a 2-DG-inhibitable energy requirement; a second calcium-requiring, EDTA-inhibitable stage; and a cyclic AMP-inhibitable step to the release of histamine and SRS-A.

MeSH Terms
Antigen-Antibody Reactions Calcium/metabolism Cyclic AMP/pharmacology Edetic Acid/pharmacology Esterases/antagonists & inhibitors,metabolism Histamine Release Humans Immunochemistry Immunoglobulin E Isoflurophate/pharmacology Isoproterenol/pharmacology Lung/enzymology,immunology,metabolism SRS-A/metabolism Time Factors
Chemicals
SRS-A Isoflurophate Immunoglobulin E Edetic Acid Cyclic AMP Esterases Isoproterenol Calcium
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Kaliner M
Austen K F
References (15)
15 references, click to expand
  1. The mechanism of histamine release in anaphylactic reaction in guinea pig and rat.
    Acta Physiol Scand. 1960 Mar 18;48:146-66 PMID: 13809018
  2. Proteolytic enzymes.
    Annu Rev Biochem. 1960;29:45-72 PMID: 14400122
  3. Anaphylaxis in chopped guinea pig lung. I. Effect of peptidase substrates and inhibitors.
    J Exp Med. 1961 Mar 1;113:521-39 PMID: 13685194
  4. Mechanism of histamine release from mast cells by cationic protein (band 2) from neutrophil lysosomes.
    J Immunol. 1971 Feb;106(2):506-16 PMID: 5545156
  5. Mechanisms of immunologic injury of rat peritoneal mast cells. I. The effect of phosphonate inhibitors on the homocytotropic antibody-mediated histamine release and the first component of rat complement.
    J Exp Med. 1966 Sep 1;124(3):379-95 PMID: 4162485
  6. Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. II. Influence of cellular levels of cyclic AMP.
    Fed Proc. 1971 Nov-Dec;30(6):1725-9 PMID: 4108129
  7. [The role of calcium ion in triggering the anaphylactic reaction in vitro].
    C R Hebd Seances Acad Sci. 1960 Feb 15;250:1375-6 PMID: 14403910
  8. Histamine release in vitro: inhibition by catecholamines and methylxanthines.
    Science. 1968 Aug 30;161(3844):902-3 PMID: 4174453
  9. Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung : I. Modulation by agents influencing cellular levels of cyclic 3',5'-adenosine monophosphate.
    J Exp Med. 1971 Sep 1;134(3):136-48 PMID: 19867362
  10. The immediate allergic response: in vitro action of cyclic AMP-active and other drugs on the two stages of histamine release.
    J Immunol. 1971 Oct;107(4):1131-6 PMID: 4106092
  11. Localization of the primary metabolic block produced by 2-deoxyglucose.
    J Biol Chem. 1957 Feb;224(2):963-9 PMID: 13405925
  12. Antibodies involved in antigen-induced release of slow reacting substance of anaphylaxis (SRS-A) in the guinea pig and rat.
    J Exp Med. 1967 Jan 1;125(1):127-47 PMID: 4163357
  13. Immunological release of histamine and slow reacting substance of anaphylaxis from human lung.
    J Exp Med. 1972 Sep 1;136(3):556-67 PMID: 4115132
  14. The immediate allergic response: in vitro separation of antigen activation, decay and histamine release.
    J Immunol. 1971 Oct;107(4):1122-30 PMID: 4106091
  15. A protein binding assay for adenosine 3':5'-cyclic monophosphate.
    Proc Natl Acad Sci U S A. 1970 Sep;67(1):305-12 PMID: 4318781
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1973-11-01
Pages
1077-94
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2139436
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com